Woman may be only person in Utah diagnosed with rare, deadly disease

TL;DR

A young woman in Davis County, Utah, has been diagnosed with a rare, degenerative, and deadly disease — and she may be the only known case in the entire state. The diagnosis underscores both the isolation patients with ultra-rare conditions face and the systemic challenges in identifying diseases that affect only a handful of people nationwide.

What Happened

A young Davis County woman has been identified as potentially the only person in Utah ever diagnosed with a rare, degenerative, and deadly disease, according to a report from KUTV 2News on July 24, 2026. The specific identity of the disease has not been publicly disclosed, and the woman’s name has not been released. The case highlights the extreme diagnostic and emotional burden carried by patients with conditions so uncommon that they may be one of only a handful of cases in the country — or, in this instance, the sole recorded patient in an entire state.

Key Facts

• The patient is a young woman from Davis County, Utah, a suburban area north of Salt Lake City with a population of roughly 370,000.
• She may be the only person in Utah ever diagnosed with this particular rare, degenerative disease, according to KUTV 2News.
• The disease is described as deadly and degenerative, meaning it progressively worsens and ultimately leads to death.
• The report aired on Friday, July 24, 2026, on KUTV 2News, a CBS affiliate serving the Salt Lake City market.
• No specific name of the disease has been made public, and the woman’s identity has been withheld to protect her privacy.
• The case represents an ultra-rare condition — defined by the National Institutes of Health as one affecting fewer than 200,000 people in the United States, though many such diseases affect far fewer.
• Davis County has no known specialist centers for ultra-rare diseases, meaning the patient likely traveled outside the area or relied on telemedicine for diagnosis and care.

Breaking It Down

The diagnosis of an ultra-rare disease in a single individual in a state with 3.5 million residents is a statistical anomaly — but not an outlier. The National Organization for Rare Disorders (NORD) estimates that 7,000 distinct rare diseases exist, and roughly 80% of them have a genetic origin. For many, the path to diagnosis takes an average of five to seven years and involves multiple misdiagnoses. In this case, the fact that a Davis County woman has been identified as possibly the only patient in Utah suggests either a newly discovered condition or one so infrequently encountered that it has never been documented in the state’s medical literature.

Fewer than 5% of the 7,000 known rare diseases have an FDA-approved treatment. That statistic, cited by the Rare Disease Clinical Research Network, frames the bleak medical reality for patients like the Davis County woman: even after a correct diagnosis, the vast majority of rare and degenerative diseases lack any effective therapy. Without a treatment, the focus shifts to symptom management, palliative care, and clinical trial enrollment — options that may be unavailable or geographically inaccessible for someone in Utah.

The degenerative nature of the disease adds another layer of urgency. Degenerative diseases — whether neurological, muscular, or metabolic — progressively erode function, often leading to loss of mobility, cognition, or organ function. For a young woman, the diagnosis likely upends her career, relationships, and long-term planning. It also raises the question of whether her case has familial implications. Many rare degenerative diseases are inherited, meaning other family members might be at risk, though no information about genetic testing has been released.

The lack of a disease name in public reporting is itself noteworthy. It may be that the condition is so new or obscure that it does not yet have a widely recognized label, or that the patient and her physicians have chosen to keep the name confidential to prevent stigma or unwanted attention. In either case, the silence underscores a broader gap: rare disease registries and surveillance systems in the United States are inconsistent, meaning many cases go uncounted or misclassified.

What Comes Next

For the patient and her care team, several immediate and mid-term developments are likely:

1. Confirmation of disease identity and genetic testing: The patient will almost certainly undergo whole-exome or whole-genome sequencing if that hasn’t already been done. Such testing can pinpoint the underlying mutation and may reveal whether other family members are carriers — or whether the condition is a spontaneous new mutation.

2. Search for other cases: Physicians and researchers will likely query the Utah Population Database (one of the largest genealogical databases in the world) and the Undiagnosed Diseases Network to see if any other patients, living or deceased, share similar symptoms. Utah’s unique family-history resources could make this search more fruitful than in most states.

3. Clinical trial exploration: If the disease has been described in medical literature, the patient may be eligible for an existing clinical trial — often located at academic medical centers such as the University of Utah Health. If no trial exists, a compassionate-use or n-of-1 treatment protocol may be considered, though these require FDA approval and sponsor cooperation.

4. Public awareness and advocacy: Rare disease advocacy groups (e.g., NORD, EveryLife Foundation) may reach out to the patient or her family. Media coverage by KUTV could prompt other undiagnosed patients in Utah to come forward, potentially revealing additional cases that were previously unrecognized.

The Bigger Picture

This story fits squarely into two broader health trends: Rare Disease Diagnosis Delays and Patient Isolation in Ultra-Rare Conditions. Studies from the EveryLife Foundation show that the average rare disease patient sees four to five doctors and receives multiple misdiagnoses over five to seven years before a correct diagnosis is made. For those with conditions that affect fewer than 20 patients nationwide, the wait can be even longer — and the emotional toll is compounded by the knowledge that no one else in their community shares their experience.

The second trend — patient isolation — is amplified by geography. A patient in Davis County, Utah, may have to travel to a major research center in Salt Lake City (30 miles) or out of state to find a specialist who has seen even one similar case. Rare disease support groups are often national or virtual, leaving the patient without a local peer. The psychological burden of bearing a “one-in-a-state” diagnosis can be as heavy as the physical symptoms.

Key Takeaways

• [Rarity Amplifies Burden]: Being the only known patient in an entire state for a deadly, degenerative disease means the patient faces extraordinary medical isolation, with few local specialists and no peer support network.
• [Diagnosis is Only the First Step]: Even after a correct diagnosis — which can take years — the vast majority of rare diseases lack approved treatments, leaving symptom management and clinical trials as the primary options.
• [Utah’s Research Advantage]: Utah’s unique genealogical databases and the presence of the University of Utah’s genetic research infrastructure could help identify additional cases or trace the disease’s inheritance pattern.
• [Media Coverage Has Real Impact]: KUTV’s reporting may help other undiagnosed patients in Utah recognize their own symptoms and seek care, potentially leading to further diagnoses and a better understanding of the disease’s prevalence.